跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
GLYCONEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule - TGA Drug Approval Details
Approvals
/
TGA
/
GLYCONEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule
Approved
STANDARD
GLYCONEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule
KSJ Pharmatech
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
bd0109efa1fdbe3b
Company
KSJ Pharmatech
Type
Standard
Approval Details
Approval Id
bd0109efa1fdbe3b
Product Name
GLYCONEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule
Artg Id
370931
Artg Name
GLYCONEO 0.5/2.5 glycopyrronium bromide (glycopyrrolate) 0.5 mg/neostigmine methylsulfate 2.5 mg in 1 mL solution for injection ampoule
Sponsor
KSJ Pharmatech
Company Detail Path
/organization/ksj-pharmatech-limited
Artg Date
2022-07-21
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0618bcbed91d1a8427cc534df5e665b9.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/8af96ae0606a880c66c4b448d29d2d74.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
bd0109efa1fdbe3b
Type
Standard
Back to TGA Approvals